Study on Fatigue in Cancer Patients During Treatment
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 125 (estimated)
- Sponsor
- University of California, San Francisco · Other
This trial is looking for cancer patients who are starting treatment with chemotherapy and radiation. Participants will answer questions and provide samples to help understand fatigue related to cancer.
You may be able to join if
- I am a cancer patient receiving treatment.
- I have not received any cancer treatments in the past month.
- I am 18 years or older.
- I can understand the consent forms.
- I can complete questionnaires and provide samples.
- I agree to have my medical records reviewed.
- I can read, write, and understand English or Spanish.
You may not be able to join if
- I cannot safely give a blood sample.
- I have received cancer treatment in the past month.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityCancer-related fatigue (CRF) is a significant problem for cancer patients. This prospective, basic science, observational study will evaluate for changes in CRF associated with molecular characteristics prior to, during, and at the completion of non-investigational, standard-of-care, combined chemotherapy and radiation therapy (CCRT) and to develop and assess predictive models for CRF severity.
Loading trial locations…